Onward Medical N.V. (EBR:ONWD)
2.485
0.00 (0.00%)
Jul 22, 2026, 10:53 AM CET
Onward Medical Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 68.11 | 60.04 | 29.77 | 41.76 | 89.44 |
Short-Term Investments | - | - | - | 20 | - |
Cash & Short-Term Investments | 68.11 | 60.04 | 29.77 | 61.76 | 89.44 |
Cash Growth | 13.44% | 101.70% | -51.80% | -30.95% | 1301.49% |
Accounts Receivable | 1.2 | 0.16 | - | - | - |
Other Receivables | 0.38 | 0.16 | 0.15 | 0.96 | 0.4 |
Total Trade Receivables | 1.58 | 0.32 | 0.15 | 0.96 | 0.4 |
Inventory | 0.8 | 0.1 | - | - | - |
Other Current Assets | 3.59 | 3.15 | 1.5 | 1.46 | 2.55 |
Total Current Assets | 74.08 | 63.62 | 31.42 | 64.18 | 92.39 |
Net Property, Plant & Equipment | 1.09 | 1.53 | 2.09 | 2.1 | 2.38 |
Other Intangible Assets | 8.73 | 10.43 | 9.8 | 10.16 | 10.03 |
Other Long-Term Assets | 0.66 | 0.57 | 0.31 | 0.16 | - |
Total Assets | 84.55 | 76.14 | 43.63 | 76.59 | 104.8 |
Accounts Payable | 3.13 | 1.27 | 1.37 | 1.91 | 0.95 |
Accrued Expenses | 6.88 | 6.79 | 4.52 | 5.67 | 4.03 |
Current Portion of Leases | 0.54 | 0.6 | 0.57 | 0.43 | 0.47 |
Other Current Liabilities | 0.55 | 0.64 | 0.22 | 0.22 | 0.08 |
Total Current Liabilities | 11.1 | 9.29 | 6.68 | 8.22 | 5.54 |
Long-Term Debt | 13.07 | 13.97 | 15.26 | 12.66 | 11.45 |
Long-Term Leases | 0.05 | 0.52 | 1.05 | 1.29 | 1.74 |
Other Long-Term Liabilities | 5.01 | 4.3 | 2.71 | 1.79 | 3.38 |
Total Long-Term Liabilities | 18.14 | 18.79 | 19.02 | 15.74 | 16.57 |
Total Liabilities | 29.24 | 28.08 | 25.7 | 23.96 | 22.11 |
Common Stock | 6.72 | 5.36 | 3.62 | 3.62 | 3.62 |
Additional Paid-in Capital | 264.35 | 217.77 | 155.25 | 155.25 | 155.25 |
Accumulated Other Comprehensive Income | 6.8 | 6.77 | 4.49 | 2.08 | -0.21 |
Retained Earnings | -222.56 | -181.85 | -145.43 | -108.32 | -75.97 |
Shareholders' Equity | 55.32 | 48.05 | 17.93 | 52.63 | 82.68 |
Total Liabilities & Equity | 84.55 | 76.14 | 43.63 | 76.59 | 104.8 |
Total Debt | 13.67 | 15.09 | 16.87 | 14.38 | 13.67 |
Net Cash (Debt) | 54.45 | 44.96 | 12.89 | 47.38 | 75.78 |
Net Cash Growth | 21.11% | 248.66% | -72.79% | -37.47% | - |
Net Cash Per Share | 1.17 | 1.01 | 0.43 | 1.57 | 7.99 |
Book Value | 55.32 | 48.05 | 17.93 | 52.63 | 82.68 |
Book Value Per Share | 1.19 | 1.08 | 0.59 | 1.74 | 8.72 |
Tangible Book Value | 46.58 | 37.63 | 8.13 | 42.47 | 72.65 |
Tangible Book Value Per Share | 1.00 | 0.84 | 0.27 | 1.41 | 7.66 |